OPEN 2027 ISHLT research funding cycle; applicant-facing competition. Application details and conflicting official deadlines require verification. Confirm current applicant requirements with ISHLT before submitting.
ISHLT-PHA 2027 Research Grant – Pulmonary Hypertension Transplantation and Patient-Centered Outcomes
FundingOne grant up to $100,000 over 2 years.
DeadlineDeadline needs funder confirmation: November 4, 2026 cycle announcement gives January 20, 2027, at 11:59 p.m. ET, while the detailed grant page says January 19 at 11:59 p.m. ET. Plan for earlier date until resolved.
Last verified2026-11-04
Required next actionRead official program at https://www.ishlt.org/grants-and-awards/grants-awards/ishlt-pha-research-grant-in-pulmonary-hypertension-transplantation--advancing-patient-centered-outcomes-and-access-to-care and apply via https://ishltgrants.secure-platform.com/site. Log in with ISHLT credentials; confirm deadline and current application prerequisites with ISHLT before submission.
Broad Eligibility
Accredited institution academic/clinical appointees and qualifying trainees; all career stages; ISHLT or PHA membership/application, institutional support letter, funding non-overlap. May include physicians, nurses, scientists, and allied professionals.
Atlas Analysis
2026-11-04 official source review. 2027 grant-cycle announcement November 4 gives Jan20 23:59 ET deadline; detailed program page Jan19 23:59 ET, conflict requires funder confirmation. One $100,000 award, 2 years, overhead max 10%, 50/25/25 installments; application questionnaire requires authenticated portal login. Source: https://www.ishlt.org/grants-and-awards/grants-awards/ishlt-pha-research-grant-in-pulmonary-hypertension-transplantation--advancing-patient-centered-outcomes-and-access-to-care. Final application requirements and the conflicting deadline remain subject to direct funder clarification.
Funding opportunity
The International Society for Heart and Lung Transplantation (ISHLT) opened its 2027 grant cycle on November 4, 2026. Patient-centered pulmonary hypertension clinical research relating to transplantation, advanced care, access barriers, patient-reported outcomes, and clinical monitoring. This is research financial assistance, not a procurement notice.
Individual applicant funding
One award up to $100,000 over two years.
Application timeline and status
The funder’s November 4, 2026 cycle-wide announcement lists January 20, 2027 at 11:59 p.m. Eastern Time as the submission deadline. The separate detailed program page currently states January 19 at 11:59 p.m. Eastern Time. These official pages conflict: applicants should confirm the deadline directly with ISHLT and plan for the earlier January 19 cutoff unless the funder clarifies. The official 2027 online portal lists this grant as accepting applications, but the member-authenticated application questionnaire has not been independently inspected.
Eligibility and restrictions
Researchers in all career stages and disciplines, including physicians, scientists, nurses and allied professionals, with an academic or clinical appointment or training at an accredited institution; institutional commitment and ISHLT or PHA membership / application are required.
Eligible expenses include research and study-personnel salaries, statistical support, materials, animals, facilities, publication and presentation travel; institutional overhead up to 10%; no other costs. Payments in 50%, 25%, 25% installments subject to progress and final reports.
How to apply
Review the official program criteria and restrictions and the official 2027 ISHLT grant application portal. Applicants need to sign in using their ISHLT account; verify current membership, institutional support, budget and submission requirements in the portal.
Research source checked November 4, 2026. Deadline and certain application details require direct funder clarification.
Source verificationReferenced source · www.ishlt.orgAtlas last verified this record 2026-11-04. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
